News, Analysis & Insights on Nutrition, Supplements, and Health
Esflorin1® Bifidobacterium longum CECT 7347 is ADM’s premier, clinically validated pro- and postbiotic for digestive health. And now, emerging research shows promise beyond digestion.
Available as a live probiotic and a heat-treated postbiotic, Esflorin1® combines strain-specific science with greater formulation flexibility. Download the clinical snapshot to review the clinical evidence and explore opportunities for digestive health innovation.
In paid partnership with ADM
Despite booming consumer interest in gut health, a lack of robust clinical data to support health claims relating to the gut microbiome remains. How can new research in pro- and postbiotics help shape next-gen products?
In paid partnership with ADM
As demand grows for products designed to support mental wellbeing, postbiotics are emerging as a promising new tool for targeting stress, sleep and mood.
Consumers are increasingly motivated to improve their long-term health, but turning good intentions into lasting habits remains a challenge.
ADM examines gut health and the gut microbiome in its latest white paper, “Precision Microbiome Control
For more product information visit ADM.